Ignite Creation Date:
2024-05-06 @ 7:26 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06016738
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2023-08-17
Brief Title:
OP-1250 Palazestrant vs Standard of Care for the Treatment of ERHER2- Advanced Breast Cancer
Sponsor:
Olema Pharmaceuticals Inc
Organization:
Olema Pharmaceuticals Inc
Organization Data
Organization:
Olema Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
OP-1250-301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Olema Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None